Well-armed immune cells help long-term nonprogressors contain HIV

December 05, 2008

To help develop an effective HIV vaccine, researchers are trying to better understand how the immune systems of a small minority of HIV-infected people known as long-term non-progressors (LTNPs) contain the virus naturally. CD8+ T cells, which kill cells infected with HIV, enable LTNPs to control HIV, but it has been unclear how CD8+ T cells mediate that control so effectively. A new report shows that the ability to stockpile two molecular weapons makes the HIV-specific CD8+ T cells of LTNPs superior cellular killers.

Lead author Stephen Migueles, M.D., senior author Mark Connors, M.D., and colleagues at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, used cutting-edge technology to examine individual CD8+ T cells for their killing prowess. The study included new techniques to measure how many HIV-infected cells each CD8+ T cell destroys, and how rapidly. In laboratory experiments, the scientists found that CD8+ T cells taken from LTNPs efficiently killed HIV-infected cells in less than 1 hour. In contrast, the CD8+ T cells of progressors, or individuals who do not contain the virus without antiretroviral therapy, killed HIV-infected cells inefficiently, even when the CD8+ T cells were present in high numbers or came from progressors being successfully treated with antiretroviral therapy.

When CD8+ T cells kill HIV-infected cells, a protein, perforin, made by the CD8+ T cells punches holes in the infected cells. Then a second protein, granzyme B, penetrates those holes and causes the cells to die. Previously, the researchers found that HIV-specific CD8+ T cells of progressors, unlike those of LTNPs, make little perforin when they encounter an HIV-infected cell. It remained unclear, however, whether this deficiency explained why HIV-specific CD8+ T cells of progressors are poor killers. The current study demonstrates a direct relationship between the quantity of both perforin and granzyme B that CD8+ T cells accumulate over time and the ability of CD8+ T cells to eliminate HIV-infected cells. This discovery significantly advances the understanding of the cellular mechanisms unique to LTNPs that explain why their immune systems, unlike those of the majority of HIV-infected people, can control HIV without antiretroviral therapy.

According to the NIAID scientists, their results also suggest that an HIV vaccine might control virus replication if it could stimulate HIV-specific CD8+ T cells to robustly stock and rapidly deliver perforin and granzyme B to HIV-infected cells.

NIH/National Institute of Allergy and Infectious Diseases

The Biology of Dendritic Cells and HIV Infection
by Sandra Gessani (Editor), Filippo Belardelli (Editor)

Dendritic cells play the most vital part in inducing anti-viral immune responses in HIV and AIDS among many other viruses. Research on dendritic cells (DCs) is emerging as a fundamental aspect for the comprehension of the mechanisms underlying the pathogenesis of viral diseases. This volume focuses on the role of DCs in the pathogenesis and immunity of HIV-1 infection. It is the only comprehensive volume on pathogenesis and immunity of Dendritic Cells that also focuses on HIV.

Histology: A Text and Atlas (Histology (Ross))
by Michael H. Ross (Author), Wojciech Pawlina (Author)

Now in its revised, updated Sixth Edition, Histology: A Text and Atlas is ideal for medical, health professions, and undergraduate biology students. This best-selling combination text and atlas includes a detailed textbook description that emphasizes clinical and functional correlates of histology, fully supplemented by vividly informative illustrations and photographs. Separate, superbly illustrated atlas sections follow almost every chapter and feature large-size, full-color digital micrographs, with labels and legends that highlight details of microanatomy.For this edition, approximately 20 percent of the micrographs have been replaced with newly enhanced, sharper images. One third of the illustrations have been redrawn in a new style.A powerful online interactive atlas is included...

The Invisible Cure: Why We Are Losing the Fight Against AIDS in Africa
by Helen Epstein (Author)

A New York Times Notable Book of 2007 The Invisible Cure is an account of Africa's AIDS epidemic from the inside--a revelatory dispatch from the intersection of village life, government intervention, and international aid. Helen Epstein left her job in the US in 1993 to move to Uganda, where she began work on a test vaccine for HIV. Once there, she met patients, doctors, politicians, and aid workers, and began exploring the problem of AIDS in Africa through the lenses of medicine, politics, economics, and sociology. Amid the catastrophic failure to reverse the epidemic, she discovered a village-based solution that could prove more effective than any network of government intervention and international aid, an intuitive response that calls into question many of the fundamental...

1997 Revised Guidelines for Performing CD4+ T-Cell Determinations in Persons Infected with Human Immunodeficiency Virus (HIV)

These revised guidelines were developed by CDC for laboratories performing
lymphocyte immunophenotyping assays in human immunodeficiency virus infected persons. This report updates previous recommendations and reflects current technology in a field that is rapidly changing. The recommendations address laboratory safety, specimen collection, specimen transport, maintenance of specimen integrity, specimen processing, flow cytometer quality control, sample analyses, data analysis, data storage, data reporting, and quality assurance.

Effect of highly active anti-retroviral therapy on markers of B cell activation in HIV infected men from the Multicenter AIDS Cohort Study: Potential impact on AIDS-lymphoma.
by Deborah Louise Regidor (Author)

Over production of B cell stimulatory cytokines and chronic B cell hyperactivation are seen in HIV infection, increasing the risk of genetic errors, which in turn may increase the risk of B cell lymphoma. In this study we tested the hypothesis that HAART will result in at least a partial normalization of serum levels of B cell-stimulatory cytokines and immune activation molecules, including sCD27, sCD30, IL6, CRP, CXCL13 and the immunoglobulins IgG, IgA, IgM and IgE. We used a retrospective cohort study design, measuring serum levels of these markers at four one-year intervals, two years prior to and two year after HAART initiation, in a sub-group of 290 HIV infected men enrolled in the Multicenter AIDS Cohort Study (MACS). Overall, we observed a reduction, but not normalization, of most...

HIV Interactions with Host Cell Proteins (Current Topics in Microbiology and Immunology)
by Paul Spearman (Editor), Eric O. Freed (Editor)

The authors seek to understand the assembly process of human immunodeficiency virus (HIV) and to develop a vaccine that can effectively neutralize HIV. HIV assembly is a process directed by the viral Gag polyprotein. Gag is a myristoylated precursor protein that is translated in the cytoplasm and then traffics to the plasma membrane or to endosomal vesicles for assembly. The authors have recently described an interaction between Gag and the delta subunit of the AP-3 adaptor protein complex (1). The mechanism and structural basis for this interaction is now under intense study. Our hypothesis is that the AP-3 interaction is responsible for the trafficking of Gag to the multivesicular body (MVB) and that this event is part of a normal productive particle assembly pathway. The Vpu protein of...

HIV and the Pathogenesis of AIDS, 3rd Edition
by Jay A. Levy (Author)

The new edition of HIV and the Pathogenesis of AIDS provides a state-of-the-art review of the current research, explains the history of the disease, and examines how scientists, clinicians, and public health workers have responded to the challenges presented by HIV/AIDS in the 25 years since its recognition. Many exciting developments in the field have deepened scientific understanding of HIV/AIDS and have provided novel approaches for prevention and treatment. The book explores potential approaches for therapy and a vaccine for the prevention of HIV infection and AIDS is discussed.

Thoroughly updated and revised, the third edition continues to provide a comprehensive analysis of the subject that is unmatched in the field. Figures and tables illustrate and emphasize key points and...

Entry Inhibitors in HIV Therapy (Milestones in Drug Therapy)
by Jacqueline D. Reeves (Editor), Cynthia A. Derdeyn (Editor)

Entry Inhibitors in HIV Therapy presents the current status of this relatively new and highly dynamic class of inhibitors and provides a unique overview of obstacles and considerations for HIV entry inhibition compared to other antiretroviral targets. The introductory chapters of this book present an overview of entry inhibitors, review current knowledge of how Env mediates entry, and discuss the challenge of genetic diversity in this region of the viral genome. Subsequent chapters feature current information on individual classes of entry inhibitors that target each step of the virus entry pathway, from attachment to membrane fusion. There is an emphasis on the complex determinants of entry inhibitor susceptibility, resistance mechanisms, the need for clinical phenotyping, and how these...

Immunology and the Quest for an HIV Vaccine: A New Perspective
by Dr. Omar Bagasra (Author)

How many human immune systems are there? How old are they? Why is there no AIDS vaccine? Is a new approach needed? Why is public opinion growing skeptical of the scientific community after three decades of public awareness about HIV/AIDS? Consider answers to these puzzling questions. Learn from the decades of experience of two senior scholars: Dr. Omar Bagasra (an eminent molecular biologist, immunologist, and retrovirologist) and Dr. Donald Gene Pace (a highly published writer who examines public health policy). Explore intriguing new possibilities about human immunity, and the development of an effective AIDS vaccine. Read Immunology and the Quest for an HIV Vaccine. Benefit from an informed synthesis backed by a wealth of peer-reviewed scientific references. Review basic concepts of...

Primer to the Immune Response: Academic Cell Update Edition
by Tak W. Mak (Author), Mary Saunders (Author)

Now available with the most current and relevant research from Cell Press, Mak's Primer to the Immune Response, Academic Cell Update Edition, gives readers both the concepts and the applications students need to know to fully grasp Immunology. Mak introduces basic concepts and then follows with specific applications in research today. This book is further enhanced by its inclusion in the Academic Cell collaboration, providing it with links to current and recently published research.Now with an online study guide with the most current, relevant research from Cell PressFull supplements including test bank, powerpoint and online self quizzingColor illustrations enhance key topics and concepts